{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T13:27:28Z","timestamp":1744637248237,"version":"3.30.1"},"reference-count":29,"publisher":"Medknow","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Res Pharm Pract"],"published-print":{"date-parts":[[2020]]},"DOI":"10.4103\/jrpp.jrpp_19_104","type":"journal-article","created":{"date-parts":[[2020,3,28]],"date-time":"2020-03-28T09:54:10Z","timestamp":1585389250000},"page":"50","source":"Crossref","is-referenced-by-count":1,"title":["Prospective study of irrational prescription of teicoplanin in a large academic hospital: a dilemma of antimicrobial resistance"],"prefix":"10.4103","volume":"9","author":[{"given":"Shadi","family":"Farsaei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masoud","family":"Hajialigol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiana","family":"Shirani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2581","reference":[{"key":"key-10.4103\/2319-9644.281544-1","first-page":"90","volume-title":"Epidemiology and risk factors of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci infections in Zhejiang China from 2015 to 2017","author":"Huang","year":"2019","journal-title":"Antimicrob Resist Infect Control"},{"key":"key-10.4103\/2319-9644.281544-2","first-page":"1763","volume-title":"Invasive methicillin-resistant Staphylococcus aureus infections in the United States","author":"Klevens","year":"2007","journal-title":"JAMA"},{"key":"key-10.4103\/2319-9644.281544-3","first-page":"111","volume-title":"Enterococcal infections and antimicrobial resistance","author":"Sood","year":"2008","journal-title":"Indian J Med Res","ISSN":"https:\/\/id.crossref.org\/issn\/0971-5916","issn-type":"print"},{"key":"key-10.4103\/2319-9644.281544-4","first-page":"327","volume-title":"Increasing resistance to vancomycin and other glycopeptides in Staphylococcus aureus","author":"Tenover","year":"2001","journal-title":"Emerg Infect Dis"},{"key":"key-10.4103\/2319-9644.281544-5","first-page":"1","volume-title":"Clinical relevance of increasing glycopeptide MICs against Staphylococcus aureus","author":"Gould","year":"2008","journal-title":"Int J Antimicrob Agents"},{"key":"key-10.4103\/2319-9644.281544-6","first-page":"322S","volume-title":"Target drug programs and medication use evaluation","author":"Hekster","year":"2000","journal-title":"Pharmacotherapy"},{"key":"key-10.4103\/2319-9644.281544-7","first-page":"305","volume-title":"Retrospective evaluation of the use of ceftolozane\/tazobactam at a large academic medical center","author":"Sacha","year":"2017","journal-title":"Infect Dis Clin Pract"},{"key":"key-10.4103\/2319-9644.281544-8","first-page":"541","volume-title":"Utilization review of systemic antiinfective agents in a teaching hospital in Tehran, Iran","author":"Ansari","year":"2001","journal-title":"Eur J Clin Pharmacol"},{"key":"key-10.4103\/2319-9644.281544-9","first-page":"384","volume-title":"Irrational antibiotic prescribing: A local issue or global concern?","author":"Hashemi","year":"2013","journal-title":"EXCLI J"},{"key":"key-10.4103\/2319-9644.281544-10","first-page":"e5060","volume-title":"Vancomycin, teicoplanin, daptomycin, and linezolid MIC creep in methicillin-resistant Staphylococcus aureus is associated with clonality","author":"Hsieh","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"key-10.4103\/2319-9644.281544-11","first-page":"533","volume-title":"Teicoplanin resistance in methicillin-resistant Staphylococcus aureus in an intensive care unit","author":"Cepeda","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"key-10.4103\/2319-9644.281544-12","first-page":"2985","volume-title":"Outbreak of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in a Parisian hospital","author":"Guerin","year":"2000","journal-title":"J Clin Microbiol"},{"key":"key-10.4103\/2319-9644.281544-13","first-page":"906","volume-title":"Quick sepsis-related organ failure assessment, systemic inflammatory response syndrome, and early warning scores for detecting clinical deterioration in infected patients outside the intensive care unit","author":"Churpek","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"key-10.4103\/2319-9644.281544-14","unstructured":"Mandell GL, Douglas RG, Bennett JE. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 8th ed. California: Elsevier Saunders; 2015."},{"key":"key-10.4103\/2319-9644.281544-15","unstructured":"SANOFI. Targocid 400mg Datapharm; 2018. Available from: https:\/\/www.medicines.org.uk\/emc\/product\/2927\/smpc. [Last updated on 2018 Feb 01; Last accessed on 2018 Jul 23]."},{"key":"key-10.4103\/2319-9644.281544-16","unstructured":"Gilbert DN, Saag MS. The Sanford Guide to Antimicrobial Therapy. 46th ed. Virginia: Antimicrobial Therapy; 2016."},{"key":"key-10.4103\/2319-9644.281544-17","first-page":"186","volume-title":"Comparison of four methods for detection of teicoplanin resistance in methicillin-resistant Staphylococcus aureus","author":"Charlesworth","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"key-10.4103\/2319-9644.281544-18","unstructured":"Wayne P. Performance Standards for Antimicrobial Susceptibility Testing 2018. CLSI Document M100-ED28. Clinical and Laboratory Standards Institute; 2018."},{"key":"key-10.4103\/2319-9644.281544-19","first-page":"525","volume-title":"Carbapenems, linezolid, teicoplanin utilization evaluation in a large teaching based hospital (Shahid Rajaie Heart Center, Tehran): A quality improvement study","author":"Farsad","year":"2016","journal-title":"BPJ"},{"key":"key-10.4103\/2319-9644.281544-20","first-page":"279","volume-title":"A new approach to Vancomycin utilization evaluation: A cross-sectional study in intensive care unit","author":"Mahmoodian","year":"2016","journal-title":"J Res Pharm Pract","ISSN":"https:\/\/id.crossref.org\/issn\/2319-9644","issn-type":"print"},{"key":"key-10.4103\/2319-9644.281544-21","first-page":"56","volume-title":"Methicillin resistant and susceptible Staphylococcus aureus: Appraising therapeutic approaches in the Northwest of Iran","author":"Hasani","year":"2013","journal-title":"Iran J Microbiol"},{"key":"key-10.4103\/2319-9644.281544-22","first-page":"217","volume-title":"Staphylococcal cassette chromosome mec (SCCmec) analysis and antimicrobial susceptibility patterns of methicillin-resistant Staphylococcus aureus (MRSA) isolates in Tehran, Iran","author":"Fatholahzadeh","year":"2008","journal-title":"Microb Drug Resist"},{"key":"key-10.4103\/2319-9644.281544-23","first-page":"736","volume-title":"Influence of teicoplanin MICs on treatment outcomes among patients with teicoplanin-treated methicillin-resistant Staphylococcus aureus bacteraemia: A hospital-based retrospective study","author":"Chang","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"key-10.4103\/2319-9644.281544-24","first-page":"736","volume-title":"Influence of teicoplanin MICs on treatment outcomes among patients with teicoplanin-treated methicillin-resistant Staphylococcus aureus bacteraemia: A hospital-based retrospective study","author":"Chang","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"key-10.4103\/2319-9644.281544-25","first-page":"471","volume-title":"What's new in the treatment of serious MRSA infection?","author":"Holmes","year":"2014","journal-title":"Curr Opin Infect Dis"},{"key":"key-10.4103\/2319-9644.281544-26","first-page":"209","volume-title":"The comparative efficacy and safety of teicoplanin and vancomycin","author":"Wood","year":"1996","journal-title":"J Antimicrob Chemother"},{"key":"key-10.4103\/2319-9644.281544-27","doi-asserted-by":"crossref","unstructured":"Svetitsky S, Leibovici L, Paul M. Comparative efficacy and safety of vancomycin versus teicoplanin: Systematic review and meta-analysis. Antimicrob Agents Chemother 2009;53:4069-79.","DOI":"10.1128\/AAC.00341-09"},{"key":"key-10.4103\/2319-9644.281544-28","first-page":"686","volume-title":"Vancomycin-resistant enterococci","author":"Cetinkaya","year":"2000","journal-title":"Clin Microbiol Rev"},{"key":"key-10.4103\/2319-9644.281544-29","first-page":"62","volume-title":"The use and therapeutic drug monitoring of teicoplanin in the UK","author":"Darley","year":"2004","journal-title":"Clin Microbiol Infect"}],"container-title":["Journal of Research in Pharmacy Practice"],"original-title":[],"language":"en","deposited":{"date-parts":[[2020,3,28]],"date-time":"2020-03-28T09:55:11Z","timestamp":1585389311000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrpp.net\/text.asp?2020\/9\/1\/50\/281544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020]]}},"alternative-id":["281544"],"URL":"https:\/\/doi.org\/10.4103\/jrpp.jrpp_19_104","relation":{},"ISSN":["2319-9644"],"issn-type":[{"type":"print","value":"2319-9644"}],"subject":[],"published":{"date-parts":[[2020]]}}}